PubMed 4. Signorile PG, Spugnini EP, Citro G, Viceconte R, Vincenzi B, Baldi F, Baldi A: Endocrine disruptors in utero cause ovarian damages linked to endometriosis. CB-839 Front Biosci 2012, 4:1724–1730.CrossRef 5. Signorile PG, Baldi F, Bussani R, D’Armiento M, De Falco M, Baldi A:

Ectopic endometrium in human foetuses is a common event and sustains the theory of mullerianosis in the pathogenesis of endometriosis, a disease that learn more predisposes to cancer. J Exp Clin Cancer Res 2009, 28:49.PubMedCentralPubMedCrossRef 6. Signorile PG, Baldi F, Bussani R, D’Armiento M, De Falco M, Boccellino M, Quagliuolo L, Baldi A: New evidences sustaining the presence of endometriosis in the human foetus. RBM online 2010, 21:142–147.PubMed 7. Signorile PG, Baldi F, Bussani R, Viceconte R, Bulzomi P, D’Armiento M, D’Avino A, Baldi A: Embryologic origin of endometriosis: analysis of 101 human female foetuses. J Cell Physiol 2012, 227:1653–1656.PubMedCrossRef 8. Signorile PG, Baldi A: Endometriosis: new concepts in the pathogenesis. Int J Biochem Cell Biol 2010, 42:778–780.PubMedCrossRef 9. Crispi S, Piccolo MT, D’Avino A, Donizetti A, Viceconte R, Spyrou M, Calogero RA, Baldi A, Signorile PG: Transcriptional Idasanutlin ic50 profiling of endometriosis tissues identifies genes related to organogenesis defects. J Cell Physiol 2013, 228:1927–1934.PubMedCrossRef 10. La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS, ESHRE Special

Interest Group for Reproductive Endocrinology–AMH Round Table: Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reproduct 2009, 24:2264–2275.CrossRef 11. Tal R, Seifer DB: Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve. Int J Endocrinol 2013, 2013:818912.PubMedCentralPubMedCrossRef 12. Wang J, Dicken C, Lustbader JW, Tortoriello DV: Evidence for a Mullerian-inhibiting substance

autocrine/paracrine system in adult human endometrium. Fertil Steril 2009, 91:1195–1203.PubMedCrossRef Cell press 13. Boccellino M, Quagliuolo L, Verde A, La Porta R, Crispi S, Piccolo MT, Vitiello A, Baldi A, Signorile PG: In vitro model of stromal and epithelial immortalized endometriotic cells. J Cell Biochem 2012, 113:1292–1301.PubMedCrossRef 14. Pepinsky RB, Sinclair LK, Chow EP, Mattaliano RJ, Manganaro TF, Donahoe PK, Cate RL: Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment. J Biol Chem 1988, 263:18961–18964.PubMed 15. Grossman MP, Nakajima ST, Fallat ME, Siow Y: Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril 2008, 89:1364–1370.PubMedCrossRef 16. Nebbioso A, Clarke N, Voltz E, Germain E, Ambrosino C, Bontempo P, Alvarez R, Schiavone EM, Ferrara F, Bresciani F, Weisz A, de Lera AR, Gronemeyer H, Altucci L: Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. Nat Med 2005, 11:77–84.PubMedCrossRef 17.